10-K: Sentient Brands Holdings Inc. Reports 2023 Annual Results Amidst Going Concern Uncertainty

Sentiment:

Annual Results


Sentient Brands Holdings Inc. reports its 2023 annual results, highlighting a net loss and ongoing concerns about its ability to continue as a going concern.

Capital raiseThe company is actively seeking additional financing through equity and debt funding.The company's future operation is dependent on its ability to secure additional financing.
Worse than expectedThe company's auditor has raised substantial doubt about its ability to continue as a going concern due to recurring losses and a working capital deficit.

Summary

  • Sentient Brands Holdings Inc. is a product development and brand management company focused on luxury and premium markets, particularly in CBD, wellness, and beauty.
  • The company's primary product line is Oeuvre, a CBD-infused skincare brand targeting high-earning individuals.
  • For the year ended December 31, 2023, Sentient Brands reported a net loss of $477,734, compared to a net loss of $734,737 in 2022.
  • The company's operating expenses decreased from $523,340 in 2022 to $250,959 in 2023, primarily due to reduced marketing and professional fees.
  • The company's accumulated deficit increased to $3,533,380 as of December 31, 2023, and it had a working capital deficit of $1,957,552.
  • The company's independent auditor has raised substantial doubt about its ability to continue as a going concern due to recurring losses and a working capital deficit.
  • The company is pursuing strategies to secure additional financing, including equity and debt funding.

Sentiment

Score: 3

Explanation: The document highlights significant financial challenges, including a substantial accumulated deficit, a working capital deficit, and a going concern warning from the auditor. While there are some positive notes about cost reduction and strategic initiatives, the overall financial picture is concerning.

Positives

  • The company reduced its net loss from $734,737 in 2022 to $477,734 in 2023.
  • Operating expenses were significantly reduced by approximately 52% year-over-year.
  • The company is actively pursuing an M&A strategy to identify high-margin, revenue-generating businesses.

Negatives

  • The company has a significant accumulated deficit of $3,533,380.
  • The company has a substantial working capital deficit of $1,957,552.
  • The company's auditor has raised concerns about its ability to continue as a going concern.
  • The company has not generated significant revenue for the years ended December 31, 2023 and 2022.

Risks

  • The company's limited operating history and recent shift in business towards product development and sales pose risks.
  • The company may fail to successfully execute its business plan, potentially leading to a loss of investment for shareholders.
  • The company's cash flow has been inadequate to support ongoing operations, and it may need to curtail future operations.
  • The company may suffer from a lack of availability of additional funds, which could force it to reduce costs or cease operations.
  • The company's commercial success is dependent on factors outside its control, such as competitor success and market acceptance.
  • The company is subject to tax risks and treatments that could negatively impact its results of operations.
  • The company faces intense competition from companies with greater resources.
  • The company's acquisition strategy creates risks, including difficulties integrating acquired businesses and potential overvaluation.
  • The company may be unable to scale its operations successfully, placing demands on management and resources.
  • The company may suffer from a lack of liquidity, which could impair its ability to operate and pursue business objectives.
  • The company's business could be adversely impacted by downturns in target markets or reduced demand for its products.
  • The company's intellectual property rights may be threatened, and it may be subject to intellectual property rights claims.
  • The company may be unable to protect the confidentiality of its trade secrets and know-how.
  • The company's stock price has experienced volatility and may continue to do so, leading to potential losses for investors.
  • The company is subject to penny stock rules, which may adversely affect the liquidity of its common stock.
  • The company's common stock is subject to restrictions on reliance on Rule 144 by shell companies or former shell companies.
  • The company does not intend to pay dividends for the foreseeable future.
  • The company may be unable to comply with financial reporting requirements, which could lead to a decline in stock price.
  • The company's product candidates are not approved by the FDA, and it faces risks of unforeseen medical problems and potential bans on sales.
  • The company and its customers may have difficulty accessing banking services, which could make it difficult to sell products and manage cash flows.
  • The company may have difficulty obtaining insurance, which could expose it to additional risk and financial liability.
  • Changes in federal and state laws could cause the company's products containing hemp-derived CBD to be illegal.

Future Outlook

The company intends to grow by leveraging its network, increasing brand awareness, and investing in social media marketing. It also plans to launch new products and pursue acquisitions. The company's future operation is dependent on its ability to secure additional financing.

Management Comments

  • The company believes it has assembled a highly accomplished team of branding and marketing professionals.
  • The company's goal is to create customer experiences that have sustainable resonance with consumers and consistently implement strategies that result in long-term profit growth for investors.

Industry Context

The market for hemp and cannabis-based products is expected to grow substantially, with forecasts reaching nearly $45 billion in the U.S. by 2024. The company is positioning itself to capitalize on this growth, particularly in the low-THC and THC-free cannabinoid sectors.

Comparison to Industry Standards

  • The company's competitors include publicly-traded companies like Charlottes Web, CV Sciences, and Elixinol, as well as private companies such as BeBoe and Lord Jones.
  • The hemp-derived CBD market is highly fragmented, with most participants generating less than $2 million in annual revenue, presenting an opportunity for Sentient Brands to establish a significant presence.
  • The company's focus on the luxury segment and its direct-to-consumer model differentiates it from some competitors.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Interim Chief Executive Officer, Interim President, Interim Chief Financial Officer, Interim Treasurer, Interim SecretaryGeorge FurlanDante Jones2022-06-20Resignation of George Furlan from interim executive roles.

Legal Proceedings

  • The company is involved in a wage dispute with a former contractor, with the contractor claiming $184,000 and the company reserving $54,000.

Stakeholder Impact

  • Shareholders face the risk of losing their investment due to the company's financial instability.
  • Employees may be affected by potential cost reductions or operational changes.
  • Customers may be impacted by the company's ability to maintain product quality and availability.
  • Creditors face the risk of non-payment due to the company's financial difficulties.

Next Steps

  • The company intends to continue its M&A strategy to identify high-margin, revenue-generating businesses.
  • The company plans to launch new products and expand its brand presence.
  • The company will continue to seek additional financing to support its operations.

Key Dates

DateDescription
2004-03-22Company incorporated in California.
2018-12-20The Agriculture Improvement Act of 2018 (Farm Bill) was signed into law.
2019-03-15Specific terms reached on $70,757 of advances with Pure Energy 714 LLC.
2019-12-26George Furlan appointed as Chief Operating Officer.
2020-01-03Specific terms reached on remaining $170,046 of advances with Pure Energy 714 LLC.
2020-03-02Effective date of the forward stock split and name change.
2020-12-02Promissory note and warrant issued to an accredited investor.
2020-12-03Convertible debenture and warrant issued to an accredited investor.
2021-01-29Company merged with its Nevada subsidiary.
2021-04-27Securities Purchase Agreement with an accredited investor for a convertible promissory note.
2021-11-18Securities Purchase Agreement with an accredited investor for a convertible promissory note.
2022-08-16Settlement Agreement and Release with Anthony L.G., PLLC and Laura Anthony, Esq.
2022-08-19Extension agreement with April 2021 investor.
2023-01-05Shares issued to settle amounts due to officers and contractors.
2023-08-09Agreement to issue shares to a qualified investor.
2023-09-28Agreement to issue shares to a qualified investor.
2023-12-03Noteholder exercised warrants to purchase common stock.
2023-12-27Noteholder exercised warrants to purchase common stock.
2024-01-23Shares issued to an investor.
2024-02-15Shares issued to an investor.
2024-02-22Shares issued to multiple investors.
2024-03-28Settlement and Release Agreement with Electro Filings LLC.
2024-04-10Shares issued in lieu of cash payment for consulting services.
2024-04-16Date of the report.

Keywords

CBD, skincare, luxury, wellness, hemp, financial results, going concern, product development, brand management, M&A

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.